Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
J Pharmacol Exp Ther
; 380(3): 210-219, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35031585
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hemoglobin, Sickle
/
Anemia, Sickle Cell
Limits:
Animals
/
Humans
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2022
Type:
Article